Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

South Africa

 

South African operators fret over amendment to Regulation 8

A draft law has been circulated that could fundamentally alter how South African healthcare operators are paid for their services. The new law would shift payment for so called prescribed minimum benefit conditions (PMBs), which must be covered by private health insurers, from an open-ended guarantee to a predetermined tariff structure.

Report: All listed healthcare service companies active in Emerging Markets

Here we present the first comprehensive list of all 57 quoted healthcare service companies which are active in Emerging Markets. The list includes companies headquartered in the Developed World, who have interests in Emerging Markets, such as Air Liquide, Fresenius or Ramsay Health Care, as well as quoted operators from the region, such as IHH, Apollo or Integrated Diagnostic Holdings. It covers everyone from Chilean hospitals to Egyptian lab operators and from NYSE quoted operators in China to big groups in Malaysia and Indonesia.

Report: Reforming China’s hospital sector

Between 2009 and 2014, the Chinese government spent over $370bn on healthcare, three times the $124bn initially planned. It is now drafting a new set of reforms in its new five-year road map to 2020, by which time total healthcare spending is expected to reach $1 trillion according to McKinsey.

Bupa growth strongest in emerging markets

The global healthcare group Bupa, experienced rapid growth in markets as diverse as Saudi Arabia, Hong Kong and Chile. It continues to make acquisitions across emerging markets, as well as launching new healthcare insurance products and distribution agreements. Global sales rose 7% to £4,916m from the first half of 2014, at constant exchange rates (CER), or 3% taken at actual exchange rates (AER). Underlying profit before taxation hit £253.3m, an increase of 2% at CER, or a fall of 3% at AER. In a wide-ranging interview, CEO Stuart Fletcher, spoke to Healthcare Nova about the results and Bupa’s future plans.

UK care industry in “serious position,” says Bupa CEO

The CEO of Bupa, Stuart Fletcher, spoke of his concern for the UK care industry, after the latest half-year results revealed a 10% fall in UK profits. Sales rose 7% to £4,916m, at constant exchange rates, or 3% taken at actual exchange rates. Underlying profit before taxation hit £253.3m, an increase of 2% at constant exchange rates (CER), but a fall of 3% taken at actual exchange rates (AER).

Will China’s five year plan help private sector?

The latest five-year plan announced by the Chinese government aims to boost private sector involvement in the healthcare industry. This signals a major shift in government policy say market insiders, and will cheer operators and investors, domestically and abroad.

Mediclinic reverses strategy and swoops on Spire

Mediclinic, the big South African hospital operator, has snapped up a 29.9% stake in Spire, the UK’s second largest hospital group for £432m. The move which might have pre-empted US buyers, surprised analysts, who said that as recently as February 2015, Mediclinic management was saying it had no plans to invest in mature, developed markets. Shares in Mediclinic at ZAR 10,317 are up just 3% on the announcement of the deal. Meanwhile, talks between Netcare, the largest South African group and Mater Private, the second largest Irish player, have collapsed.

Mediclinic reverses strategy and swoops on Spire

Mediclinic, the big South African hospital operator, has snapped up a 29.9% stake in Spire, the UK’s second largest hospital group for £432m. The move surprised analysts, who said that as recently as February 2015, Mediclinic management was saying it had no plans to invest in mature, developed markets. Shares in Mediclinic at ZAR 10,317 are up just 3% on the announcement of the deal. Meanwhile, talks between Netcare, the largest South African group and Mater Private, the second largest Irish player, have collapsed.

Hassab Labs looks to catch up with IDH

Egypt’s third largest lab group, Hassab Labs, is targeting North Africa as it ramps up its expansion plans. CEO Mohamed Azab says a partnership with the pan-African, Saham Insurance, will provide opportunities there and across the rest of the continent. But is it too late?

Find Us